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Antigen recognition by T lymphocytes initiates a series of events that ultimately
lead to expression of functional activities, e.g., lymphokine secretion in helper T
cellsor delivery of the lethal hit in CTL. The earliest changes detectable after TCR
triggering are a rise in the concentration ofpolyphosphoinositide breakdown prod-
ucts, inositoltrisphosphate (IP3) and diacylglycerol (DAG) (1). IP3 appears to cause
a rise in cytosolic Ca2+ concentration by release of Cat+ from intracellular stores
(2), and DAG is an activator of PKC (3). These consequences ofantigen recognition
can be artificially induced by mAbs against the TCR or against the TCRassociated
CD3 molecules. In addition, mAbs directed to other surface molecules that define
"alternative" activation pathways such as CD2 (4) induce the same events (5).
The interaction ofmAbs with most ofthese molecules leads to their transient removal
from the cell surface, a process termed modulation. Modulation of CD2 (6) or Tp44
(7, 8) leads to unresponsiveness to the respective mAb but has no influence on other
pathways. In contrast, modulation of the TCR/CD3 complex that is also a conse-
quence of antigen-specific triggering results in a transient state of refractoriness to
any signal given via a surface molecule (6, 8). The mechanism leading to this general
unresponsiveness is not known. Recently it has been shown that in TCR/CD3-
modulated Jurkat leukemia cells the early metabolic steps, i.e., formation of IP3
and increase in Ca2+ concentration do not take place (9) . In this report, we dem-
onstrate that a TCRassociated GTP-binding protein is functionally inactivated by
TCR modulation.
Volume 168 August 1988 817-822
Materials and Methods
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Cells.
￿
Human CD8+ CTL clones or lineswere obtained as described (10) and propagated
in growth medium consisting of RPMI-1640 with 5% AB serum and 20 U/ml rIL-2 .
Reagents.
￿
All chemicals were obtained from Sigma Chemical Co., Munich, FRG. Anti-
CD3 or anti-CD8 mAbs were purified from the supernatant of OKT3 or OKT8 hybridoma
cell lines. The anti-CD8 mAb BMA081 (IgG2a) and the anti-CD3 mAb BMA030 (IgG2a)
were a gift from Dr. R. Kurrle, Behring Werke AG, Marburg. Purified goat anti-mouse IgG
antibodies were obtained from Tago Inc., Burlingame, CA. a toxin from Staphylococcus aureus
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was purchased from Calbiochem, Frankfurt, FRG. It was furtherpurified by subsequent precipi-
tations with 65% (vol/vol) and 55% (vol/vol) saturated ammonium sulphate solution. Precipitate
was dialyzed against assay buffer. The hemolytic activity was determined with 0.05 m12 .5%
rabbit erythrocytes in PBS as described (11). 1 U of a toxin is defined as the amount of a
toxin required to cause halfmaximal hemolysis.
Permeabilization.
￿
CTL were permeabilized in a buffered medium (assay medium) con-
sisting of 150 mM potassium glutamate, 5 mM nitriloacetic acid, 10 mM Pipes, and 0.5 mM
EGTA, pH 6.9, adjusted with KOH (12). If not specified otherwise, this medium contained
50 4M free Cat' and 1 mM ATP. The exact free Caz' concentrations in the medium were
calculated by means of a computer program using the stability constants given (13). CTL
were permeabilized with a toxin from S. aureus by adding 30 U a toxin/106 cells directly to
the assay.
Measurement of Serine Esterase Release.
￿
CD8' CTL (usually 0.8 x 105 cells/well) were in-
cubated in U-shaped 96-well microtiter plates (Nunc, Wiesbaden, FRG) at 37°C. After 45
min, incubation plates were centrifuged at 100 g for 3 min, and 25 wl samples of supernatant
were harvested. Activity of serinesterase in the supernatant (14) was measured by a modification
ofthe method of Coleman and Green (15). Briefly, 25-u1 samples of supernatant were mixed
with 225 ul of substrate solution (0.2 mM BIT and 0.22 mM DTNB in 200 mM Tris-HCl,
pH 8.05). The mixture was incubated at 37°C for 20 min. Absorbance at 405 nm was mea-
sured in comparison with a blank solution that was treated exactly as experimental . Maximal
release was determined by using 0.1% Triton X-100 solubilized cells. Spontaneous release
was determined in supernatants of unstimulated nonpermeabilized cells. Data are given as
percent esterase release = (experimental release - spontaneous release) : (maximal release -
spontaneous release) x 100. Data represent mean of triplicates ± SD.
Modulation.
￿
Removal of surface antigens was performed by incubating the cells for 16 h
in growth medium containing 4 ug/ml of the respective mAb. The success of modulation
was controlled by cell sorter analysis.
Results and Discussion
The exocytotic release of the granule enzyme BLTserine esterase by normal human
CD8+ CTL was used as an assay for CTL triggering. Although the role of the var-
ious constituents of these granules in CTL killing is unclear, the release of the CTL-
specific serine esterase is a useful marker ofCTL activation per se, since it is com-
pleted within a short time and does not require cellular interactions (16).
To gain access to the interior ofthe CTL, we permeabilized the plasma membrane
with the a toxin ofS. aureus. This toxin is an ideal permeabilizing agent since upon
contact with the target lipid bilayer the a toxin monomers self-associate to form small
transmembrane channels. These pores represent a homogeneous population of ring
structured hexamers with a defined pore diameter and do not allow passage of
molecules with a molecular weight >4,000 daltons (17, 18). Since a toxin monomers
cannot pass through these pores, the action ofa toxin is strictly confined to the plasma
membrane (12, 19). In preliminary experiments, we determined that only low
molecular weight components, and not cytosolic enzymes, were released from the
permeabilized CTL (not shown).
These pores allowed us to permanently introduce the membrane-impermeable
guanosine-nucleotide analogues GTPyS and GDPRS in defined concentrations into
the cell. GTPyS is a poorly hydrolysable GTP analogue that is able to irreversibly
activate all G proteins, whereas GDPRS inactivates all G proteins (20). As shown
in Fig. 1, in the presence of Ca2+ and ATP, GTPyS is able to cause release of the
serine esterase from permeabilized CTL. That this release is due to stimulation of
exocytosis via the action of GTPyS on a G protein and not to nonspecific effectsAdditions
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serine esterase release was de-
termined .
is suggestedby the fact that the cytosolicenzyme lactatedehydrogenase is notreleased
(not shown) . Under the same conditions, GDPOS has no effect, nor has GTP'YS an
effect on nonpermeabilized intact cells . Therefore, in CTL, exocytosis can be trig-
gered by activation of aG protein provided Cat+ and ATP are present. The re-
quirement for exogenous Cat+ is probably due to the fact that the assay medium
has a high buffering capacity for Cat+ and will buffer all Ca2+ released intracellu-
larly by IP3 .
We next showed that transmembrane signal transduction via theTCR/CD3 com-
plex was functional also in permeabilized CTL. CTL were permeabilized and in-
cubatedwith immobilized anti-CD3 mAbs . As shownin Fig . 2, such CTLresponded
with esterase release in the absence ofGTPyS . To show that this triggering viaCD3
involvesG protein, we used theG protein-inhibiting compound GDPOS . IfGDP(3S
was added to the assay, exocytosis of esterase triggered by immobilized anti-CD3
mAbs was inhibited by 60%. In contrast, the response to thePKC activator 1-oleyl-
2-acetyl-rac-glycerol (OAG) that also triggers serine esterase release in the presence
ofCA" and ATP was not inhibited . This indicates that GDPOS inhibits a G pro-
FIGURE 2 .
￿
Inhibition ofTCRtrig-
gered exocytosis by GDPPS . Perme-
abilized CD8' CTL were incu-
bated with medium alone or 60 uM
OAGor immobilizedOKT3 (anti-
CD3) in the presence of 50 AIM free
Cat' and 1mM ATP . To immobi-
lize OKT3, the wells ofa 96-well mi-
crotiter plate were precoated with
goat anti-mouse IgG antibodies . 8
x 10 4 CTL per well were in-
cubated at 37'C for 45 min . Solid
bars represent percent serine esterase
release (±SD) in the absence of
GDPDS, and hatched bars represent
release in the presence of 180 uM
GDPpS . Inhibition is significant at
p<0.005 (') as determined by Stu-
dent's t test .820
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TABLE I
Modulation of the CD3 Complex Leads to Inactivation of the G protein
Permeabilized CD8+ CTL (0.8 x 105 cells/well) were incubated with GTPyS or OAG in
the concentrations indicated.
' Cells were incubated for 16 h at 37°C with 4 wg/ml BMA030 (Anti-CD3) or 4 wg/ml BMA081
(anti-CD8), respectively.
1 Difference from control was highly significant (p < 0.001) based on student's 1-test .
teinthat acts earlyin the stimulus secretion coupling, most likely directlyafterTCR
triggering and before the formation of DAG.
To determine the relationship ofthe G protein to the TCR, we modulated the
TCR/CD3 complex from the surface ofthe CTL. The success ofmodulation was
controlled by cell sorter analysis. As shown inTable I, theresponse ofC133-modulated
permeabilized CTL to GTPySwasreduced by>77%. Modulation ofCD8 as a con-
trol did not lead to a reduction ofGTPyS-stimulated exocytosis. Most importantly,
if C133-modulated permeabilized CTL were stimulated with OAG in the presence
of Cat+ and ATP, exocytosis was not inhibited compared with unmodulated per-
meabilized CTL. This shows that the exocytotic apparatus can still be triggered by
second messengers (Ca2+, DAG) that bypass transmembrane signalling.
Takentogether, ourdatasuggest that in normal human CTL, aGprotein is func-
tionally inactivated after TCR modulation. This G protein is involved in TCR
mediated triggering ofexocytosis and can be localized in the sequence ofsignalling
steps after CD3 and before the formation of DAG. It therefore appears to mediate
the receptor-induced activation of phospholipase C.
Why does TCR modulation lead to general nonresponsiveness? A possible expla-
nation is that this G protein is also used to transmit signals received by other ac-
tivatingmolecules, e.g., CD2 orTp44. It is likely that the G protein is not only func-
tionally, but alsophysically, associated with the TCR. Its removal together with the
TCR would lead to a general loss of transduction potential.
Summary
TCR modulation induced by antiTCR or anti-CD3 mAbs leads to a transient
state of refractoriness of the T cell to all signals given via cell surface structures.
To investigate the underlying mechanisms, we have used human CTL permeabi-
lized with the a toxin ofS aureus . This method ofpermeabilization allows manipu-
lation ofthe interior milieu of the cell, but maintains its functional and structural
integrity. Introduction of the Gprotein activator GTPyS into permeabilized CTL
leads to triggering ofgranule exocytosis. The Gprotein inactivator GDPOS inhibited
exocytosis induced by TCR triggeringbut not that induced by activation ofprotein
kinase C. This indicates that the G protein that triggers exocytosis is localized after
CD3 triggering but before formation ofthe polyphosphoinositol breakdown product
CTL line Percent serine esterase release from cells stimulated with:
modulated with` - 20 pM GTPyS 100 4M GTPyS 60 gM OAG
- 4.212.1 15.6±1.2 34.0 f0.3 22.2 0.7
Anti-CD3 mAb 1 .3 t 2.3 2.6 ± 1.51 7.5 t 2 .21 20.1 ± 2.5
Anti-CD8 mAb 3.3 t 1 .3 16.0 f 3.6 34.2 t 1 .1 25.9 t 2.3SCHREZENMEIER ET AL.
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diacylglycerol. In TCRmodulated CTL, GTPyS is no longer able to activate exo-
cytosis. Such CTL, however, still respond to PKC activators. This demonstrates that
a TCRassociatedG protein has been functionally inactivated by TCR modulation.
We thank R. Mahmoudi for typing this manuscript.
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